Frank Glavin
Chief Executive Officer at Meissa Vaccines
Based in Cambridge, United States
7-day free trial · no credit card
Seniority
C-Team
Department
General Business & Management
Location
Cambridge
Industry
Biotechnology Research
Company size
11
Contact information
Reveal Frank's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
f•••••••@meissavaccines.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Frank Glavin
Catalyzing Chief Executive focused on developing breakthrough therapies and technologies. Currently CEO of Meissa Vaccines, a clinical stage company whose mission is to protect people everywhere from life-threatening respiratory viruses. Meissa is advancing live attenuated vaccine candidates against respiratory syncytial virus (RSV), SARS-CoV-2 (COVID-19), and human metapneumovirus (hMPV) developed using the company’s proprietary AttenuBlock synthetic biology platform. Previously grew Orphan Technologies from the lab to the clinic culminating in a >$500MM acquisition. Data driven problem solver willing to collaboratively tackle complex and long-term challenges with internal and external stakeholders. Lead communicator to external and internal constituencies including academic collaborators, ownership, and fellow Board members. Happiest helping great science benefit patients
Decision-makers
Other people at Meissa Vaccines
Build a list of verified contacts at Meissa Vaccines
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Frank
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime